ESCFX Mutual Fund

ESCFX Mutual Fund

NAV$18.00
See how much of ESCFX you already own
Just $25 once·$99/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Jul 31, 2026

Net Assets
$1M
Expense Ratio
1.13%
Dividend Yield (Current)
-
Holdings
104
Inception Date
Jul 11, 2022
Fund Family
1290 Funds
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO

Performance

YTD+9.69%
1 Year+12.61%
3 Year+21.50%

Asset Allocation

Stocks: 96.57%
Cash: 2.55%
Other: 0.88%
See how much of ESCFX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report comes with FundXLS. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
KNSA:LNKiniksa Pharmaceuticals, Ltd.2.61%
LINCLincoln Educational Services Corp2.53%
DRSLeonardo DRS Inc2.39%
JIMXXJpmorgan Prime Money2.29%
ADPTAdaptive Biotechnologies Corp2.23%
Top 10 Concentration: 21.43%Report Date: Jul 31, 2026
Download all 104 holdings for ESCFX
CSV export with sector, industry & share changes
Get CSV

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

ESCFX Mutual Fund Overview

ESCFX Mutual Fund (1290 Essex Small Cap Growth Fund) is managed by 1290 Funds with $1.3M in net assets. ESCFX expense ratio is 1.13%, holding 104 positions across sectors including Information Technology, Industrials, Health Care. Inception date: 2022-07-11.

ESCFX performance shows a YTD return of 9.69%. The 1-year return is 12.61%.

ESCFX top holdings include Kiniksa Pharmaceuticals, Ltd. (2.6%), Lincoln Educational Services Corp (2.5%), Leonardo DRS Inc (2.4%), Jpmorgan Prime Money (2.3%), Adaptive Biotechnologies Corp (2.2%). Go to all ESCFX holdings, ESCFX sectors, or ESCFX dividends.

ESCFX can be compared against other funds. Use ESCFX overlap to find shared positions, or ESCFX vs another fund for a side-by-side view. ESCFX alternatives are available via the screener, along with tax-loss harvesting opportunities.